A young Texas woman who underwent a double mastectomy she now deeply regrets can move forward with her lawsuit against the therapist who recommended the surgery, the Texas Supreme Court ruled, reversing two lower courts that had tried to shut the case down on a technicality.
The decision in Aldaco v. Wood, Case No. 24-1069, sends the case back to a district court for a full hearing, and adds fuel to a growing legal reckoning over gender-transition procedures that were once treated as beyond question by much of the medical establishment.
Soren Aldaco, now 23, filed suit in 2023 against therapist Barbara Wood, Wood's employer Thriveworks, and the Crane Clinic, where the surgery took place. She alleged negligence and fraud, claiming Wood signed a letter endorsing the mastectomy that misrepresented the extent of Aldaco's treatment for gender dysphoria, and that Wood's decision to sign it was, in Aldaco's words, "a severe departure from any recognized standard of care."
The facts laid out in the court's opinion paint a grim picture. Wood conducted telehealth sessions with Aldaco to discuss relationship issues. On February 22, 2021, Wood signed a letter endorsing Aldaco for surgery. Aldaco's psychotherapy with Wood continued until May 14, 2021. Less than a month later, on June 11, 2021, Aldaco went under the knife at the Crane Clinic for a double mastectomy.
The Texas Supreme Court's own language was blunt, as Legal Newsline reported:
"But the surgery Aldaco had hoped would solve her problems only made them worse. She experienced post-surgical complications that required emergency medical care. Research and self-reflection ultimately led her to regret the life-changing and body-altering procedure she'd once embraced."
Wood and Thriveworks tried to escape the lawsuit by arguing the clock had run out. Under the Texas Medical Liability Act, patients have two years to bring a malpractice claim. The defendants argued that the statute began running when Wood signed the recommendation letter in February 2021, meaning Aldaco's 2023 lawsuit came too late.
A trial court agreed. A court of appeals affirmed. Aldaco's case appeared dead.
The Texas Supreme Court saw it differently. The justices found that Aldaco could not have ascertained her bodily injury until after her psychotherapy treatment with Wood concluded on May 14, 2021. Because Aldaco gave pre-suit notice within two years of that date, she satisfied the statute of limitations.
The court stated plainly: "By giving presuit notice within two years of Wood's completion of treatment, therefore, Aldaco satisfied the statute of limitations." And: "Aldaco's claims against Wood are not time-barred under (the TMLA)."
The ruling reversed the court of appeals and sent the case back to district court. Whether Aldaco ultimately prevails on the merits remains to be seen. But the procedural barrier that two lower courts used to block her has been removed.
The distinction matters beyond this single case. If courts had accepted the defendants' argument, that the clock starts when a therapist signs a recommendation letter, not when treatment ends or harm becomes apparent, it would have created a nearly impossible timeline for patients to bring claims. Many would discover their injuries only after the window had already closed.
Aldaco's allegations go well beyond a simple disagreement over treatment. She has described a process in which medical professionals failed to explore her underlying psychological distress and instead fast-tracked her toward irreversible surgery. The New York Post reported that Aldaco was prescribed testosterone and estrogen blockers after just a 30-minute consultation with a nurse practitioner at age 17.
Aldaco has spoken publicly about what she experienced. In her own words: "Through this journey of self-exploration, I have come to realize how coercive gender-identity ideology was for me, disguising harm as compassion."
She also alleged her surgeon coached her on "talking points" to secure insurance coverage for the mastectomy, a procedure she says was subsequently botched.
The broader picture of Aldaco's teenage years is troubling. Fox News reported that Aldaco's therapist allegedly wrote the surgical recommendation letter falsely stating she had lived as male for 12 months, a clinical milestone she had not reached. Aldaco also claimed her therapist showed no interest in exploring her history of being groomed online, despite her explicit requests to discuss it.
The Supreme Court's willingness to take up cases touching gender-identity policy at both the state and federal level reflects the growing legal and cultural weight of these disputes.
"I discovered the darkest corners of the internet," Aldaco told Fox News. "In these chatrooms, I was sexually groomed by adult strangers who used my love for art against me." She also noted that her stepmother, not a legal guardian, was the one who took her to appointments, and that practitioners never asked whether the adult accompanying her had legal authority.
Aldaco's case does not exist in isolation. It arrives in the wake of a verdict that has already reshaped the legal landscape for gender-transition providers.
In January 2026, a 22-year-old named Fox Varian won a $2 million jury verdict against a surgeon and psychologist in New York for facilitating her double mastectomy at age 16. It was the first detransitioner malpractice case to go to trial and win in U.S. history.
The fallout was swift. The Washington Examiner reported that within days of the Varian verdict, the American Society of Plastic Surgeons and the American Medical Association both reversed their positions, recommending against gender-affirming surgeries for minors. Major hospital systems, including NYU Langone, Baystate Health, and Vanderbilt University Medical Center, shut down or scaled back transgender youth programs.
Attorney John Ramer, who represents Aldaco, framed the stakes in stark terms: "What was done to Ms. Aldaco and many people like her is a medical scandal. Kids and young adults suffering from severe psychological distress went looking for help, and what they found is medical providers saying that what's going to liberate them from their distress is pumping them full of cross-sex hormones and cutting off their body parts."
As The Atlantic's Helen Lewis observed after the Varian verdict: "American doctors are no longer united on the wisdom of medicalizing gender dysphoria in minors."
That fracture is now reaching courtrooms. The question confronting the medical profession is no longer whether these lawsuits will come, it is how many, and how large.
For years, critics warned that the "gender-affirming care" model, in which therapists and doctors were expected to validate a patient's self-diagnosis and move quickly toward hormones and surgery, created enormous risks for vulnerable young people. Those warnings were dismissed as bigotry or fearmongering by professional associations, hospital administrators, and progressive politicians who insisted the science was settled.
The science, it turns out, was not settled. The professional consensus was not a consensus. And the patients who were harmed are now old enough to hire lawyers.
What makes the Aldaco case particularly instructive is the role of the therapist. This was not a surgeon wielding a scalpel. Barbara Wood was the gatekeeper, the professional whose letter of recommendation was required before the Crane Clinic would proceed. Aldaco alleges that letter was fraudulent, that it overstated the depth of her treatment, and that Wood signed it without adequate clinical basis.
If those allegations are proved at trial, the implications extend far beyond one therapist in Texas. The entire referral pipeline, from therapist to surgeon to insurer, comes under scrutiny. Every recommendation letter signed with insufficient clinical grounding becomes potential evidence of malpractice.
The debate over how political leaders handle gender-transition questions involving minors continues to intensify. Maryland Governor Wes Moore drew sharp criticism for saying he would support his minor son's gender transition, a position that looks increasingly out of step with the direction of both medical opinion and legal liability.
The Texas Supreme Court's ruling does not determine whether Aldaco wins her case. It determines only that she gets to make her case. The district court will now hear the merits, the allegations of negligence, fraud, and departure from the standard of care.
Several questions remain unanswered. What specific post-surgical complications did Aldaco suffer? What does the full text of Wood's recommendation letter say? Are there other defendants whose claims are being addressed separately? And how will the Varian verdict in New York, and the institutional reversals it triggered, shape the standard of care arguments in a Texas courtroom?
The broader trajectory, though, is unmistakable. The institutions that once insisted gender-transition procedures for minors and young adults were safe, evidence-based, and morally imperative are now scrambling to distance themselves from those positions. The professional associations are rewriting their guidelines. The hospitals are closing their clinics. And the patients who were told this would fix everything are lining up to tell judges what actually happened.
Justice Clarence Thomas has warned about the dangers of ideological capture within American institutions. The gender-medicine pipeline, from online chatrooms to therapist offices to operating rooms, may prove to be one of the most consequential examples of exactly that phenomenon.
Soren Aldaco lost parts of her body she can never get back. The least the legal system can do is let her ask a jury why.
